pamidronate has been researched along with Porphyrias in 2 studies
Porphyrias: A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe the case of a patient who developed reversible retrobulbar optic neuritis after intravenous pamidronate therapy for established osteoporosis." | 7.69 | Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria. ( Body, JJ; des Grottes, JM; Dumon, JC; Schrooyen, M, 1997) |
| "We describe the case of a patient who developed reversible retrobulbar optic neuritis after intravenous pamidronate therapy for established osteoporosis." | 3.69 | Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria. ( Body, JJ; des Grottes, JM; Dumon, JC; Schrooyen, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reading, PJ | 1 |
| Newman, PK | 1 |
| Kelly, WF | 1 |
| Bateson, MC | 1 |
| Rothwell, P | 1 |
| des Grottes, JM | 1 |
| Schrooyen, M | 1 |
| Dumon, JC | 1 |
| Body, JJ | 1 |
2 other studies available for pamidronate and Porphyrias
| Article | Year |
|---|---|
Treatment of immobilisation hypercalcaemia in acute intermittent porphyria: experience from three cases.
Topics: Acute Disease; Adolescent; Adult; Diphosphonates; Female; Humans; Hypercalcemia; Pamidronate; Porphy | 1997 |
Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria.
Topics: Anti-Inflammatory Agents; Diphosphonates; Evoked Potentials, Visual; Female; Humans; Infusions, Intr | 1997 |